Trials / Completed
CompletedNCT00113620
Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic Neuropathy
A Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of Dextromethorphan and Quinidine at Two Dose Levels in the Treatment of the Pain of Diabetic Neuropathy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 450 (estimated)
- Sponsor
- Avanir Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether dextromethorphan (Neurodex) and quinidine are effective in the treatment of pain of diabetic neuropathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Neurodex |
Timeline
- Start date
- 2005-07-01
- Primary completion
- 2007-02-01
- Completion
- 2007-02-01
- First posted
- 2005-06-10
- Last updated
- 2016-07-14
Locations
44 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00113620. Inclusion in this directory is not an endorsement.